GWANC
REGN icon

Guardian Wealth Advisors (North Carolina)’s Regeneron Pharmaceuticals REGN Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Sell
430
-13
-3% -$8.85K 0.02% 331
2026
Q1 		$342K Hold
443
– – 0.02% 268
2025
Q4 		$342K Buy
443
+14
+3% +$9.51K 0.02% 275
2025
Q3 		$241K Sell
429
-8
-2% -$4.52K 0.02% 316
2025
Q2 		$229K Buy
437
+38
+10% +$21.2K 0.02% 309
2025
Q1 		$253K Buy
399
+2
+0.5% +$1.38K 0.02% 274
2024
Q4 		$283K Sell
397
-15
-4% -$12.6K 0.02% 259
2024
Q3 		$433K Sell
412
-12
-3% -$13.4K 0.05% 178
2024
Q2 		$446K Sell
424
-2
-0.5% -$1.94K 0.05% 170
2024
Q1 		$410K Buy
426
+21
+5% +$20K 0.05% 180
2023
Q4 		$356K Sell
405
-14
-3% -$11.5K 0.05% 174
2023
Q3 		$345K Buy
419
+30
+8% +$23.6K 0.06% 167
2023
Q2 		$280K Buy
389
+36
+10% +$27.8K 0.05% 176
2023
Q1 		$290K Buy
353
+4
+1% +$3.02K 0.05% 170
2022
Q4 		$252K Sell
349
-140
-29% -$103K 0.05% 169
2022
Q3 		$337K Sell
489
-12
-2% -$7.55K 0.06% 135
2022
Q2 		$296K Sell
501
-73
-13% -$47.5K 0.05% 148
2022
Q1 		$401K Sell
574
-78
-12% -$49.3K 0.17% 100
2021
Q4 		$412K Buy
+652
New +$401K 0.18% 103

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s REGN Position: Q2 2026 in Review

Guardian Wealth Advisors (North Carolina) reduced its Regeneron Pharmaceuticals (REGN) stake by 2.9% in Q2 2026, selling an estimated $8.85K and leaving 430 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #331.

Guardian Wealth Advisors (North Carolina) first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $446K in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Guardian Wealth Advisors (North Carolina) held 430 shares of Regeneron Pharmaceuticals worth $268K as of Q2 2026.
  • Guardian Wealth Advisors (North Carolina) sold 13 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.85K.
  • Regeneron Pharmaceuticals made up 0.02% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #331 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Guardian Wealth Advisors (North Carolina)'s Regeneron Pharmaceuticals position peaked at $446K in Q2 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.